Clinical trial
Prospective Study on the Role of Radical Prostatectomy in Oligo-metastatic Hormone-sensitive Prostate Cancer in Patients on Androgen Deprivation Therapy
NCT07766486 is registered in ClinicalTrials.gov with Fondazione del Piemonte per l'Oncologia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Study on the Role of Radical Prostatectomy in Oligo-metastatic Hormone-sensitive Prostate Cancer in Patients on Androgen Deprivation Therapy
- Lead sponsor
- Fondazione del Piemonte per l'Oncologia
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- September 26, 2019
- Completion date
- December 31, 2030
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
oligometastatic hormone-sensitive prostate cancer, prostate adenocarcinoma